Skip to main content
. Author manuscript; available in PMC: 2019 Aug 1.
Published in final edited form as: Leukemia. 2018 Oct 12;33(2):554–558. doi: 10.1038/s41375-018-0274-y

Figure 1. Treatment outcomes in study cohort.

Figure 1

(A) Overall survival and (B) relapse-free survival by trial/decade. (C) Overall survival and (D) relapse-free survival by CR status and decade of therapy (1980s/1990s versus 2000s/2010s). (E) Overall survival and (F) relapse-free survival in patients treated on S0106 who achieved morphologic CR with the first cycle of 7+3, stratified by results from MRD test, assessed centrally by multiparameter flow cytometry.